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Summary
Keratin 12 (K12) is an intermediate-filament protein ex-
pressed specifically in corneal epithelium. Recently, we
isolated K12 cDNA from a human corneal epithelial
cDNA library and determined its full sequence. Herein,
we present the exon-intron boundary structure and chro-
mosomal localization of human K12. In addition, we
report four K12 mutations in Meesmann corneal epi-
thelial dystrophy (MCD), an autosomal dominant dis-
order characterized by intraepithelial microcysts and
corneal epithelial fragility in which mutations in keratin
3 (K3) and K12 have recently been implicated. In the
human K12 gene, we identified seven introns, defining
eight individual exons that cover the coding sequence.
Together the exons and introns span ∼6 kb of genomic
DNA. Using FISH, we found that the K12 gene mapped
to 17q12, where a type I keratin cluster exists. In this
study, four new K12 mutations (Arg135Gly, Arg135Ile,
Tyr429Asp, and Leu140Arg) were identified in three un-
related MCD pedigrees and in one individual with
MCD. All mutations were either in the highly conserved
a-helix–initiation motif of rod domain 1A or in the a-
helix–termination motif of rod domain 2B. These sites
are essential for keratin filament assembly, suggesting
that the mutations described above may be causative for
MCD. Of particular interest, one of these mutations
(Tyr429Asp), detected in both affected individuals in one
of our pedigrees, is the first mutation to be identified
within the a-helix–termination motif in type I keratin.
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Introduction
Keratin proteins are structurally important intermediate
filaments found in all epithelial tissues. Obligate heter-
opolymers in which a highly conserved a-helical central
rod domain is surrounded by nonhelical terminal se-
quences, the family of keratin proteins is further divided
into type I (acidic; K9–K21) or type II (neutral or basic;
K1–K8) components (Hatzfeld and Weber 1990; Lu and
Lane 1990), the expression of which is both tissue spe-
cific and dependent on the stage of differentiation of the
particular epithelial cell line (Moll et al. 1982).
Several inherited epidermal diseases, such as epider-
molysis bullosa simplex (EBS), are caused by keratin
mutations (Bonifas et al. 1991; Coulombe et al. 1991;
Cheng et al. 1992; Lane et al. 1992; Chan et al. 1993;
Chen et al. 1993; Hovnanian et al. 1993; Humphries et
al. 1993; Rugg et al. 1993; Stephens et al. 1993;
Scamsher et al. 1995), and a mutation hot spot in keratin
genes is recognized to be within both the a-he-
lix–initiation motif, at the rod domain–1A segment, and
the a-helix–termination motif, at the rod domain–2B
segment (Lane 1994). These segments have been shown
to have functional importance (Hatzfeld and Weber
1991; Vassar et al. 1991; Geisler et al. 1992; Letai et al.
1992; Wilson et al. 1992; Steinert et al. 1993).
The corneal epithelium, a layer of five or six cells that
covers the anterior corneal surface, is a hugely important
barrier that protects the underlying cornea from envi-
ronmental factors. We know that corneal epithelial cells
specifically and predominantly express keratin 3 (K3)
and keratin 12 (K12) (Moll et al. 1982; Schermer et al.
1986; Kurpakus et at. 1990; Liu et al. 1993), suggesting
that these proteins form the obligate heterodimer of cor-
neal epithelial keratin intermediate filaments.
The human K3 gene has been cloned and character-
ized (Klinge et al. 1987 [GenBank accession numbers
X05418, X05419, X05420, andX05421]), and in recent
years the rabbit K3 gene (Wu et al. 1994 [GenBank
accession number X74371]) and the murine K12 gene
(Liu et al. 1994 [GenBank accession number U08095])
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Figure 1 Slit-lamp photograph of patient FM (see fig. 3) with
MCD, showing numerous intraepithelial microcysts (arrows) in the
central cornea.
Figure 2 Micrograph of a portion of a basal epithelial cell from
MCD patient TM (see fig. 3). Numerous electron-lucent intracyto-
plasmic spaces (*) are evident, and an electron-dense “myeloid struc-
ture,” as reported by Nakanishi and Brown (1975), is also documented
(arrow). N  nucleus. Scale bar  720 nm.
have also been isolated and characterized. In addition,
our group has isolated human K12 cDNA from a human
corneal epithelial cDNA library and has determined its
complete sequence (Nishida et al. 1996 [GenBank ac-
cession number D78367]). Recently, the importance of
K12 in the corneal epithelium has been highlighted by
the finding that K12 knockout mice possess fragile cor-
neal epithelia (Kao et al. 1996).
Meesmann corneal epithelial dystrophy (MCD; MIM
122100), also known as “juvenile hereditary epithelial
dystrophy,” is a rare, bilateral, and symmetric dystrophy
that is inherited as an autosomal dominant trait (Mees-
mann andWilke 1939). The clinical appearance ofMCD
is characterized by intraepithelial microcysts (fig. 1),
which are visible on slit-lamp examination within the
1st year of life. These increase in number with age, al-
though the patients tend to remain asymptomatic until
late adolescence when the cysts can break through the
epithelial surface, causing lacrimation, photophobia,
and pain. Histopathologically, Periodic acid Schiff-pos-
itive materials are found intracytoplasmically in the ab-
normal epithelial regions, via impression cytology. Also,
a “peculiar substance,” thought to be the result of cy-
toplasmic filament degeneration (Kuwabara and Cic-
carelli 1964), is occasionally found in the epithelial cells,
and myeloid structures (documented in one of our pa-
tients; fig. 2) have been found intracytoplasmically (Nak-
anishi and Brown 1975).
Since, clinically, MCD has a number of features in
common with various epidermal keratin diseases that
have been linked to mutations in keratin genes, we
sought to determine the human K12 exon-intron bound-
ary structure, document its chromosomal localization,
and search for K12 mutations in three unrelated Japa-
nese families and one individual with MCD.
Material and Methods
Genomic Cloning , Exon/Intron Structure, and Chro-
mosomal Localization of the Human K12 Gene
cDNA clones that we previously had isolated (Nishida
et al. 1996) were used as probes to screen a human
genomic library in l-FIX II (Stratagene). Primers for the
K12 cDNA sequences were designed for reference to the
murine K12 gene structure as reported elsewhere (Liu
et al. 1994). Both K12 cDNA and a genomic clone F327
were used as templates for PCR. Positions of introns
were identified by comparing the products from both
cDNA and genomic DNA. Fragments that were larger
after amplification from genomic DNA were sequenced
directly, by use of PCR primers. Sequencing was per-
formed with the Taq dideoxy terminator cycle-sequenc-
ing kit (Applied Biosystems), according to the manufac-
turer’s protocol. Sequence reactions were resolved on
an ABI PRISM 377 automated sequencer (Applied
Biosystems).
FISH was used to identify the chromosomal locali-
zation of the human K12 gene. DNA from clone F327
was labeled with digoxigenin dUTP (Boehringer Mann-
heim) by nick translation. Labeled probe was combined
with sheared human DNA and hybridized to normal
metaphase chromosomes derived from phytohemagglu-
tinin-stimulated peripheral blood lymphocytes from a
male donor, in a solution containing 50% formamide,
10% dextran sulfate, and . Specific hybridi-2 # SSC
zation signals were detected by incubating the hybridized
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Table 1
Primers for PCR Direct Sequencing
Presumptive
Exon 5′ Pimer 3′ Primer
1 GCATGTCTGCTTCCAGTGTT TAAAGTGGAGTGAAACAACC
2 TAGTATTTTAGGGCTTCAATC AGGCAGGACAGTAGGACAGA
3 GCAAGAAATAGCCCTGAAGA ATTTTTGGGTTTGGGAGGAA
4 GGCCCAAGAGGACAAAAGTA GCAGGCCTTTCTGTGAATGT
5 AGAAAGGCCTGCGAAACGAG AAAGAGGAGGGTAGCCAACG
6 GTCCCCTCCATCGTTATTTC CTATTTCTGCTGCCCACTCT
7 TCCATTAAAAGCCAGGTTGT GGTCTTACAGGTTTTGCATT
8 GCCTACATTAAACAACCAGT TGACCAAAATGACTTGTGACTG
slides in fluoresceinated antidigoxigenin antibodies, fol-
lowed by counterstaining with DAPI.
Reverese Transcriptase–PCR (RT-PCR) and K12/K3
cDNA Sequence
This study was conducted in accordance with the prin-
ciples of the Declaration of Helsinki regarding research
involving human subjects and was approved by the In-
stitutional Review Board onHuman Experiments,Kyoto
Prefectural University of Medicine. Informed consent
was obtained from all our human subjects. With a
Quick-Prep mRNA Purification kit (Pharmacia-LKB),
mRNA was purified from the corneal epithelium of an
MCD patient (TM, an affected individual in our MCD-
T family) who had received a corneal transplant because
of a secondary corneal opacity unrelated to dystrophic
abnormality. cDNA was generated as described else-
where (Nishida et al. 1995). RT-PCR was performed by
use of primer pairs covering an open reading frame of
K3 and K12. PCR products were directly sequenced by
use of several sequencing primers designed for deter-
mining the full sequence of K3 and K12 cDNA. With
proper informed consent, cDNA from normal human
corneal epithelia obtained at autopsy was analyzed as a
positive control.
Mutation Analysis
We studied K12 as a candidate gene for MCD in four
families—denoted as “N,” “K,” “T,” and “F”—in
whom a clinical diagnosis of MCD was confirmed his-
topathologically via impression cytology. We searched
for a mutation in the a-helix rod domain by SSCP anal-
ysis and sequencing of amplified genomic DNA. For
SSCP, PCR was performed by use of the following oli-
gonucleotide primer pairs: For helix initiation, we used
K12/347F (GCTCTCTAGGTATTCTCTCG) and K12/
556R (CCTGAGTCTTCAATCAGTGG), and, for helix
termination, we used the exon 6 5′ and exon 6 3′ primers
shown in table 1. These regions are thought to possess
functional importance (Hatzfeld and Weber 1991; Vas-
sar et al. 1991; Geisler et al. 1992; Letai et al. 1992;
Wilson et al. 1992; Steinert et al. 1993), and mutations
there are known to cause keratin diseases other than
MCD (Lane 1994). PCR for the helix-termination motif
was followed by restriction-enzyme Eco47I (Toyobo) di-
gestion. To look at other regions, we used primers for
exon-specific amplification, shown in table 1. Denatured
samples were electrophoresed for 12–20 h at 4 W in a
cooled room. Migration was performed on a 7% poly-
acrylamide gel containing 10% glycerol. After migra-
tion, the gel was stained with green nucleic-1 # SYBR
acid gel-stain solution (Molecular Probes) and was
analyzed by use of a laser-scanning image analyzer
(FluorImager 595; Molecular Dynamics).
The sequencing was performed by use of an automatic
fluorescent DNA sequencer (ABI PRISM 377; Applied
Biosystems). Primers for amplification of individual ex-
ons, except for the 5′ primer for presumptive exon 1 and
the 3′ primer for presumptive exon 8, were designed from
adjacent intron sequences within 100 bp of the splice
site. The 3′ primer for exon 8 was designed in the 3′
UTR region. Exon 1 spans the head domains (E1, V1,
and H1) and the 1A segment of the a-helix domain. H1
and 1A are mutation hot spots, whereas E1 and V1 are
polymorphic; therefore, the 5′ primer for exon 1 was
designed in the E1/V1 region. Genomic DNA (50 ng)
was amplified with AmpliTaq gold polymerase (Perkin
Elmer) in buffer supplied by the manufac-1 # PCR
turer. The primers (5′r3′) are shown in table 1.
Restriction-enzyme digestion (i.e., RFLP) analysis was
performed to confirm the mutations, to test for cose-
gregation, and to show that the mutations do not occur
in 100 normal unrelated chromosomes. Since, among
the four mutations that we report, three do not alter
any known restriction site, we synthesized primers that
contained mismatches; these are given here with the mis-
match bases underlined. For the mutation Arg135Gly in
our MCD-N family, we used the primers K12/NF
(GGAGGTGGCTCTCTAGGTATT) and K12/NR
(CTTATCCAGGTAGGAAGCTGGT), which generate
an Eco47I (Toyobo) site in the mutated allele but not
in the normal allele; for the mutation Arg135Ile in our
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Table 2
Exon/Intron Boundary Sequences of K12
Presumptive
Exon intron/EXON . . . EXON/intron
K12 cDNA
(Nucleotide Positionsa)
Exon Length
(bp)
1 . . . CAGGAATAAGgtaagatctc !1–567 1567
2 cttttgccagATCATTTCAG . . . TCAGGATGAAgtgagtcgaa 568–650 83
3 tggttttcagGTATGAGAAT . . . CCACGAGGATgtgagtcaga 651–807 257
4 ctgtccccagGAGCTCCAAA . . . CATTGAAAAGgtaacacaaa 808–969 162
5 gctgttgcagAGCGGGGAGC . . . GCTCGCCATGgtaggctcgt 970–1095 126
6 ccacgtgcagAAGAAATCCC . . . AGGCCCAAGGgtgagcagac 1096–1316 221
7 tttcttacagTGATGGTTTG . . . TCCTCTAAAGgtatgcagaa 1317–1387 71
8 ttatctttagACCCAACCAA . . . 1388–1844! 1457
a Numbers refer to positions of the cDNA, with the first nucleotide of the open reading frame being 1.
MCD-K family, we used the primers K12/KF (GAA-
AAAGAAACTATGCAAAATCTTAATGAAA) and
K12/KR (CATTCTCGAATTTTATTTTCTAGCTCA-
GTA), which generate a SspI (Toyobo) site in the
mutated allele but not in the normal allele; for the mu-
tation Tyr429Asp in our MCD-T family, we used the
primers K12/TF (TGGAGCTGGAGATTGAGGTC)and
K12/TR (ACTCTTGGTCAGCCCCTGAA), which gen-
erate a SalI (Takara) site in the mutated allele but not
in the normal allele; and, for the mutation Leu140Arg
in our MCD-F family, we used the primers K12/FF
(GCAATGATGGAGGCCTTCTT) and K12/FR
(AGCTCAGTATTAGCCTCTTCT), which generate a
HapII (Takara) site in the mutated allele but not in the
normal allele. Migration was performed on a 4%
NuSieve agarose gel.
Results
Genomic clones of human K12 were isolated from a
human genomic library. One of the clones, F327, was
analyzed by PCR amplification and subsequent direct
sequencing. Seven introns were identified, thereby defin-
ing eight individual exons that cover the coding se-
quence. Together the exons and introns span ∼6 kb of
genomic DNA. The exon-intron boundary sequences
will appear in the DDBJ, EMBL, and GenBank nucle-
otide-sequence databases, with the following acces-
sion numbers: AB007115, AB007116, AB007117,
AB007118, and AB007119. These all conform to the
canonical splice-donor and -acceptor sequences. Partial
nucleotide sequences are given in table 2.
Using FISH, we mapped the human K12 gene to chro-
mosome 17q12 (data not shown), where a type I keratin
cluster exists. This supports the recent finding by Irvine
et al. (1997), who assigned the human K12 gene to chro-
mosome 17q (in the interval between D17S800 and
D17S930), using the Genebridge 4 radiation-hybrid
panel.
We were able to sequence K12 and K3 cDNAs ob-
tained from the corneal epithelium of one MCD patient
(an affected individual denoted as “TM” in our MCD-
T family), who had a corneal transplant because of a
secondary corneal opacity unrelated to the dystrophic
abnormality. This analysis showed a TrG transversion
in codon 429 in K12, whereas no mutation was detected
in K3 cDNA (data not shown).
Using a combination of SSCP (data not shown) and
sequencing of amplified genomic DNA (fig. 3), we found
K12 mutations in all ourMCD families. In familyMCD-
N, all affected individuals heterozygously had an ArG
transition at the first nucleotide position in codon 135.
This transition predicts the substitution of an Arg (AGA)
by a Gly (GGA) at codon 135 (a substitution designated
as “Arg135Gly”) within the highly conserved helix-in-
itiation motif of rod domain 1A (fig. 3a). Similarly, in
family MCD-K, all affected individuals heterozygously
had a GrT transversion at the second nucleotide posi-
tion in codon 135, resulting in an Arg135Ile substitution
(fig. 3c). In family MCD-T, both affected individuals had
a TrG transversion at the first nucleotide position in
codon 429. This transversion is within the highly con-
served helix-termination motif of rod domain 2B and
results in a Tyr429Asp substitution (fig. 3e). SSCP, direct
sequencing of genomic DNA, and RFLP analyses
showed that the mutations in all three families com-
pletely cosegregated with the disease phenotype. Finally,
the MCD-F individual had a TrG transversion at the
second nucleotide position in codon 140 within the con-
served domain 1A, resulting in a Leu140Arg substitution
(fig. 3g). A cosegregation study in this family could not
be performed, because of the patient’s refusal to give
consent. By repeating the amplification procedures and
sequence analyses, we verified that the documented tran-
sition or transversions were not due to polymerase errors
during PCR. All mutations were detected when we se-
quenced in both the forward and the reverse directions,
and, when the PCR product was subcloned, bothmutant
and normal alleles were detected. Also, we sequenced all
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Figure 3 Direct sequencing and restriction-enzyme–digestion analysis of the K12 gene in MCD. In the pedigrees males are represented
by squares, females by circles. Affected individuals are represented by blackened symbols, and the proband in each family is indicated by an
arrow. Sequencing was performed in both directions; the results shown (a, c, e, and g) are in the antisense direction. The left-hand portion of
each sequencing panel shows results for an unaffected control, whereas the right-hand portion shows results for a family member affected with
MCD. a, K12 sequence within the helix-initiation motif of rod domain 1A in family MCD-N (results for patient NM are shown), showing an
ArG transition at the first nucleotide position in codon 135 that results in an Arg135Gly substitution. b, RFLP analysis, using a mismatch
primer, in family MCD-N. The K12 mutation creates a new Eco47I site. This mutation-specific Eco47I digestion pattern cosegregated with the
disease phenotype. c, K12 sequence within the helix-initiation motif of rod domain 1A in family MCD-K (results for patient KE are shown),
showing a GrT transversion at the second nucleotide position in codon 135 that results in an Arg135Ile substitution. d, RFLP analysis, using
a mismatch primer, in family MCD-F. The K12 mutation creates a new SspI site. This mutation-specific SspI digestion pattern cosegregated. e,
K12 sequence within the helix-termination motif of rod domain 2B in family MCD-T (results for patient TM are shown), showing a TrG
transversion at the first nucleotide position in codon 429 that results in a Tyr429Asp substitution. f, RFLP analysis, using a mismatch primer,
in family MCD-T. The K12 mutation creates a new SalI site. This mutation-specific SalI digestion pattern cosegregated. g, K12 sequence within
the helix-initiation motif of rod domain 1A in family MCD-F (results for patient FM are shown), showing a TrG transversion at the second
nucleotide position in codon 140 that results in a Leu140Arg substitution. h, RFLP analysis in family MCD-F. The K12 mutation creates a
new HapII site. This mutation-specific HapII digestion pattern was detected in affected patient FM but not in normal individuals.
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Figure 4 Depiction of the domain structure of K12 and the
mutations found in MCD. The rod domain comprises a-helical seg-
ments 1A, 1B, 2A, and 2B, flanked by the nonhelical head and tail
domains. The vertical line in the middle of segment 2B represents the
“stutter” that is an interruption in the phasing of the heptad repeat.
The helix-initiation and -termination motifs are denoted by hatched
boxes at the beginning and end of the rod domain, respectively. The
amino acid sequences for the helix-initiation and -termination motifs
are shown.
coding regions of the K12 gene in affected individuals
from each family and checked individual exons covering
the regions other than the a-helix–initiation or –termi-
nation motif. Apart from the mutations described, no
other substitutions or polymorphisms were found in the
rod domain of K12.
RFLP analyses showed that the mutations that we
report completely cosegregated with the disease phe-
notype within each of the three families (MCD-N,MCD-
K, and MCD-T) that participated in our cosegregation
study (fig. 3b, d, and f). Although we were not permit-
ted to perform a cosegragation study of family MCD-F,
the mutation detected in the affected individual was con-
firmed by RFLP (fig. 3h). All four mutations described
were excluded from 100 normal unrelated
chromosomes.
Discussion
MCD corneas possess a fragile epithelium, and the
clinical presentation of the cornea closely resembles sev-
eral blistering epidermal diseases caused by mutations
in epidermal keratins. This clinical picture, along with
several pathological features shared by MCD and some
epidermal diseases, led us to postulate that MCD might
be caused by a mutation in K12 or K3, keratins that are
expressed specifically in the corneal epithelium.Recently,
our suspicions were proved true by a study that docu-
mented K3 and K12 mutations in MCD (Irvine et al.
1997). This showed that K12 mutations exist at posi-
tions 135 (Arg135Thr) and 143 (Val143Leu) in MCD
patients from an Irish pedigree and from Meesmann’s
original German kindred. We have also found mutations
at position 135 (Arg135Gly and Arg135Ile) in two of
our four Japanese pedigrees, although no mutation at
position 143 was detected in any of our MCD patients.
In addition, the present study identifies two extra mu-
tations (Tyr429Asp and Leu140Arg) not present in the
Irish or German MCD families that recently have been
reported (Irvine et al. 1997).
The mutations that we detected are located in the
helix-initiation motif of the 1A segment (mutations
Arg135Gly, Arg135Ile, and Leu140Arg) in two Japanese
families and one individual with MCD and in the helix-
terminationmotif at the end of the 2B segment (mutation
Tyr429Asp) in another family (fig. 4). When family
members could be tested, these mutations completely
cosegregated and were absent from normal individuals.
The regions in which the MCD mutations occur are
highly conserved among intermediate-filament chains
and are thought to play important roles in filament as-
sembly and stability. Several lines of evidence show that
the regions in which our mutations occur represent a
mutation hot spot in the keratin gene, in several inherited
epidermal diseases. Substitutions of the Arg residue at
position 135 in K12 in families MCD-N and MCD-K
are in some ways analogous to (a) the Arg-residue sub-
stitution in codon 125 in K14 in EBS–Dowling-Meara
(EBS-DM) (Coulombe et al. 1991; Stephens et al. 1993),
(b) the Arg-residue substitution in codon 156 in K10 in
bullous ichthyosiform erythema (BCIE) (McLean et al.
1994) and in epidermolytic hyperkeratosis (EHK) (Roth-
nagel et al. 1992), (c) the Arg residue substitution in
codon 162 in K9 in patients with epidermolytic pal-
moplatar keratoderma (EPPK) (Reis et al. 1994), and
(d) the Arg residue substitution in codon 127 in K16 in
nonepidermolytic palmoplanter keratoderma patients
(Scamsher et al. 1995). It is curious that, in families
MCD-N and MCD-K, the Arg substitution at codon 10
in the helix-initiation motif (position 135 in the case of
K12) does not occur in a CpG dinucleotide, whereas, in
the aforementioned diseases, Arg substitutions in this
position in K9, K10, K14, and K16 all occur in CpG
dinucleotides; the significance of this remains unkown.
We know that the more severe phenotypes of EBS-
DM are caused by mutations in the helix-initiation or
helix-termination motif (Coulombe et al. 1991; Stephens
et al. 1993), whereas the milder forms (EBS–Weber-
Cockayne and EBS-Ko¨bner) are associated with muta-
tions at other sites (Rugg et al. 1993). Drawing analogies
with MCD, we can infer that all affected individuals in
the four MCD families that we studied should represent
the severe phenotype. Indeed, this would seem to be the
case, because, although vision is not diminished enough
to require a corneal graft (it rarely is with MCD), intra-
epithelial microcysts in all individuals are extensive, and
subjective findings such as photophobia, lacrimation,
and itching are strong. As with EBS, we cannot rule out
the possibility that a mild form of MCD may exist,
caused by mutations at sites other than the helix-initi-
ation or -termination motif as documented here.
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In assessing the importance of the K12 mutations in
the MCD families that we studied, it is useful to consider
some ultrastructural aspects of keratins more closely.
These proteins, of which types 3 and 12 are found in
cornea, are intermediate filaments, whose structure de-
pends on the positions of polar and nonpolar residues
in their a-helical segments. Basically, keratins are com-
posed of two parallel a-helical segments (one type I and
one type II) that lie in register. The amino acid sequence
in the helical rod domains comprises repeating amino
acid sequences possessing seven residues, (a–g)n, where
a and d are usually nonpolar residues and the others are
usually polar or charged residues (Parry et al. 1977;
Coulombe and Fuchs 1990; Hovnanian et al. 1993).
This heptad model of keratin ultrastructure dictates that
the polar residues a and d form a hydrophobic core at
the center of the heterodimer. In addition, the polar res-
idues e and g, located adjacent to the hydrophobic core,
stabilize the dimer via ionic interactions. Since all the
mutations found in our study change a polar residue
into a nonpolar residue, or vice versa, they should result
in the loss of either an ionic bond or a hydrophobic
interaction, thereby destabilizing the keratin filament
and possibly giving rise to MCD.
Of particular interest here is the discovery of a sub-
stitution, in the helix-termination motif in type I keratin,
that was found in both of the affected individuals in
family MCD-T. This region is the most highly conserved
motif in intermediate-filament sequences. In family
MCD-T, the affected individual (TM) whose cornea was
grafted showed no other mutations in the a-helix do-
main in either K12 or K3, by RT-PCR and subsequent
direct sequence analysis. These K12 data were confirmed
at the genomic level. Taking these results together with
those showing that this new mutation (Tyr429Asp) was
present in TM’s affected sibling but not in either his
unaffected sibling or 100 normal individuals, we pro-
pose that it may be causative for MCD. To the best of
our knowledge, no investigators have documented sub-
stitutions in the helix-termination motif in a type I ker-
atin that are causative for epidermal keratin diseases.
Nevertheless, the possibility that a mutation in the helix-
termination motif in type I keratin may cause MCD is
not totally unexpected, since mutations in this motif are
known, for example, in type II keratins in patients with
EBS (Lane et al. 1992; Rothnagel et al. 1992). Also, it
is worth noting that previous in vitro experiments show-
ing that the helix-termination motif in type I keratin is
important for keratin filament assembly/function (Hatz-
feld and Weber 1991; Letai et al. 1992; Wilson et al.
1992) are indirectly supported by our finding that in
family MCD-T a Tyr residue in codon 429 in the helix-
termination domain in K12 may well be important for
the interaction of K3 and K12.
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